SCHEMBL4167482

SCHEMBL4167482

[CH2]CCCCCCCCCCOCCOCCOCCOc1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.56
APP P05067 1/20 0.51
LTA4H P09960 3/20 0.49
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
RARB P10826 1/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SLCO1B3 Q9NPD5 1/20 0.41
SLCO1B1 Q9Y6L6 1/20 0.41
PRMT1 Q99873 2/20 0.40
F2 P00734 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17784366 0.91 NR5A1 (0.66) NR5A1LTA4HDRD2DRD4DRD3
SCHEMBL17784372 0.91 NR5A1 (0.66) NR5A1LTA4HDRD2DRD4DRD3
SCHEMBL17784353 0.91 NR5A1 (0.66) NR5A1LTA4HDRD2DRD4DRD3
SCHEMBL7465840 0.89 NR5A1 (0.62) NR5A1APPLTA4HDRD2DRD4
SCHEMBL24799496 0.85 APP (0.61) NR5A1APPLTA4HDRD2DRD4
SCHEMBL8674641 0.84 NR5A1 (0.58) NR5A1APPLTA4HMEN1USP2
SCHEMBL2471330 0.83 APP (0.67) NR5A1APPLTA4HDRD2DRD4
SCHEMBL19284359 0.83 APP (0.67) NR5A1APPLTA4HDRD2DRD4
SCHEMBL6860317 0.83 APP (0.67) NR5A1APPLTA4HDRD2DRD4
SCHEMBL10357881 0.83 NR5A1 (0.83) NR5A1APPLTA4HRARBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163380-A1 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STRATOS BIOSYSTEMS, LLC (US) 2009-06-25 US disclosed
WO-2007133714-A2 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STRATOS BIOSYSTEMS, LLC (US) 2007-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163380-A1 ANALYTE FOCUSING BIOCHIPS FOR AFFINITY MASS SPECTROMETRY STUB1, SPR, DBI NR5A1 2146/4885APP 1320/4885LTA4H 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.